NO20043850L - 10-(3-Cyklopropylaminometyl-1-pyrrolidinyl) pyridobenzo ksazinkarboksylsyrerederivater effektive mot medikament-resistente bakterier - Google Patents
10-(3-Cyklopropylaminometyl-1-pyrrolidinyl) pyridobenzo ksazinkarboksylsyrerederivater effektive mot medikament-resistente bakterierInfo
- Publication number
- NO20043850L NO20043850L NO20043850A NO20043850A NO20043850L NO 20043850 L NO20043850 L NO 20043850L NO 20043850 A NO20043850 A NO 20043850A NO 20043850 A NO20043850 A NO 20043850A NO 20043850 L NO20043850 L NO 20043850L
- Authority
- NO
- Norway
- Prior art keywords
- group
- hydrogen atom
- resistant bacteria
- kazazine
- pyridobenzo
- Prior art date
Links
- -1 3-Cyclopropylaminomethyl-1-pyrrolidinyl Chemical group 0.000 title abstract 2
- 241000894006 Bacteria Species 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 229910052731 fluorine Inorganic materials 0.000 abstract 3
- 125000001153 fluoro group Chemical group F* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 102100025142 Beta-microseminoprotein Human genes 0.000 abstract 1
- 241000192125 Firmicutes Species 0.000 abstract 1
- 101100185029 Homo sapiens MSMB gene Proteins 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002074783 | 2002-03-18 | ||
| JP2002369205 | 2002-12-20 | ||
| PCT/JP2003/002967 WO2003078439A1 (fr) | 2002-03-18 | 2003-03-13 | Derive d'acide 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylique efficace contre les bacteries resistantes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043850L true NO20043850L (no) | 2004-09-14 |
Family
ID=28043757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043850A NO20043850L (no) | 2002-03-18 | 2004-09-14 | 10-(3-Cyklopropylaminometyl-1-pyrrolidinyl) pyridobenzo ksazinkarboksylsyrerederivater effektive mot medikament-resistente bakterier |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7153851B2 (fr) |
| EP (1) | EP1486500B1 (fr) |
| JP (1) | JP4468701B2 (fr) |
| KR (1) | KR20040094806A (fr) |
| CN (1) | CN1653071A (fr) |
| AT (1) | ATE443064T1 (fr) |
| AU (1) | AU2003213335B8 (fr) |
| BR (1) | BR0308643A (fr) |
| CA (1) | CA2478763A1 (fr) |
| DE (1) | DE60329280D1 (fr) |
| MX (1) | MXPA04009026A (fr) |
| NO (1) | NO20043850L (fr) |
| NZ (1) | NZ535182A (fr) |
| WO (1) | WO2003078439A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005026147A1 (fr) * | 2003-09-10 | 2005-03-24 | Kyorin Pharmaceutical Co., Ltd. | Derive d'acide quinolonecarboxylique 7-(4-substitue 3-cyclopropylaminomethyl-1-pyrrolidinyle) |
| NZ533360A (en) | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| JPWO2006009143A1 (ja) * | 2004-07-21 | 2008-05-01 | 杏林製薬株式会社 | （３ｓ）−３−ヒドロキシメチル−７−オキソピリドベンゾオキサジン−６−カルボン酸エステルの製造方法 |
| GB0428250D0 (en) * | 2004-12-23 | 2005-01-26 | Novartis Ag | Organic compounds |
| EP1992613B1 (fr) * | 2006-03-09 | 2013-01-30 | Kyorin Pharmaceutical Co., Ltd. | Procede de production d'un derive pyrrolidine 3,4-disubstitue et intermediaire de production |
| NZ601080A (en) * | 2010-01-08 | 2014-03-28 | Kyorin Seiyaku Kk | Method for producing 3,4-disubstituted pyrrolidine derivative and production intermediate thereof |
| KR20130086532A (ko) * | 2010-05-31 | 2013-08-02 | 교린 세이야꾸 가부시키 가이샤 | 3-치환-4-플루오로피롤리딘 유도체의 제조 방법 |
| AU2011321551A1 (en) | 2010-10-25 | 2013-05-09 | Kyorin Pharmaceutical Co., Ltd. | Method for producing 3,4-disubstituted pyrrolidine derivative |
| CN102276628A (zh) * | 2011-06-21 | 2011-12-14 | 周崇科 | 氟喹诺酮类化合物及其合成方法 |
| CA2910112C (fr) | 2013-04-25 | 2021-02-16 | Kyorin Pharmaceutical Co., Ltd. | Composition pharmaceutique solide |
| US20180042918A1 (en) * | 2015-03-13 | 2018-02-15 | Kyorin Pharmaceutical Co., Ltd. | Respiratory infection treating agent |
| GB201708606D0 (en) | 2017-05-30 | 2017-07-12 | King S College London | Antibiotic resistance breakers |
| TW202415375A (zh) * | 2017-06-16 | 2024-04-16 | 日商杏林製藥股份有限公司 | 吸入性肺炎、肺化膿症或肺膿瘍之治療劑 |
| EP4110758A1 (fr) * | 2020-02-25 | 2023-01-04 | Tes Pharma S.r.l. | Composés hétérocycliques pour la modulation de nr2f6 |
| CN112194667B (zh) * | 2020-11-06 | 2021-08-17 | 湖南科技大学 | 取代1,4-苯并噁嗪并二氮卓类化合物及其制备方法和用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4822801A (en) * | 1984-07-20 | 1989-04-18 | Warner-Lambert Company | 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents |
| JPS62155282A (ja) | 1985-12-27 | 1987-07-10 | Sankyo Co Ltd | ピリドベンゾオキサジンカルボン酸誘導体 |
| ID16655A (id) | 1996-04-24 | 1997-10-30 | Daiichi Seiyaku Co | Turunan-turunan sikloalkilaminometilpirolidina |
| JPH10287669A (ja) * | 1997-04-10 | 1998-10-27 | Dai Ichi Seiyaku Co Ltd | 置換アミノメチルピロリジン誘導体 |
-
2003
- 2003-03-13 KR KR10-2004-7014519A patent/KR20040094806A/ko not_active Ceased
- 2003-03-13 AU AU2003213335A patent/AU2003213335B8/en not_active Ceased
- 2003-03-13 CN CNA038113465A patent/CN1653071A/zh active Pending
- 2003-03-13 CA CA002478763A patent/CA2478763A1/fr not_active Abandoned
- 2003-03-13 JP JP2003576444A patent/JP4468701B2/ja not_active Expired - Fee Related
- 2003-03-13 AT AT03708575T patent/ATE443064T1/de not_active IP Right Cessation
- 2003-03-13 MX MXPA04009026A patent/MXPA04009026A/es active IP Right Grant
- 2003-03-13 WO PCT/JP2003/002967 patent/WO2003078439A1/fr not_active Ceased
- 2003-03-13 BR BR0308643-7A patent/BR0308643A/pt not_active IP Right Cessation
- 2003-03-13 DE DE60329280T patent/DE60329280D1/de not_active Expired - Lifetime
- 2003-03-13 EP EP03708575A patent/EP1486500B1/fr not_active Expired - Lifetime
- 2003-03-13 NZ NZ535182A patent/NZ535182A/en unknown
- 2003-03-13 US US10/508,154 patent/US7153851B2/en not_active Expired - Fee Related
-
2004
- 2004-09-14 NO NO20043850A patent/NO20043850L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04009026A (es) | 2005-01-25 |
| JP4468701B2 (ja) | 2010-05-26 |
| CA2478763A1 (fr) | 2003-09-25 |
| DE60329280D1 (de) | 2009-10-29 |
| AU2003213335B8 (en) | 2009-04-02 |
| EP1486500A4 (fr) | 2006-02-08 |
| AU2003213335A1 (en) | 2003-09-29 |
| EP1486500A1 (fr) | 2004-12-15 |
| US7153851B2 (en) | 2006-12-26 |
| AU2003213335B2 (en) | 2008-09-11 |
| BR0308643A (pt) | 2005-02-09 |
| JPWO2003078439A1 (ja) | 2005-07-14 |
| US20050182052A1 (en) | 2005-08-18 |
| WO2003078439A1 (fr) | 2003-09-25 |
| CN1653071A (zh) | 2005-08-10 |
| ATE443064T1 (de) | 2009-10-15 |
| EP1486500B1 (fr) | 2009-09-16 |
| NZ535182A (en) | 2006-02-24 |
| KR20040094806A (ko) | 2004-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20043850L (no) | 10-(3-Cyklopropylaminometyl-1-pyrrolidinyl) pyridobenzo ksazinkarboksylsyrerederivater effektive mot medikament-resistente bakterier | |
| EA200100755A1 (ru) | 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты | |
| ATE420847T1 (de) | Substituiertes phenylalkansäurederivat und dessen verwendung | |
| ID17851A (id) | Persenyawaan heterosiklis, produksi dan pemakaiannya | |
| CY1109835T1 (el) | Πυρανονες χρησιμες ως αναστολεις της atm | |
| EA200400981A1 (ru) | Новые гетероциклические соединения, активные в качестве ингибиторов бета-лактамаз | |
| FI931763A0 (fi) | 4,1-bensoxazepinderivat och deras anvaendning | |
| DK0790987T3 (da) | Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer | |
| ATE374773T1 (de) | Polycyclische verbindungen als potenten alpha2- adrenoceptor antagonisten | |
| WO2003059900A1 (fr) | Derives de coumarine, leur procede de production et d'utilisation | |
| NO942757L (no) | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-okso-kinolin-derivater | |
| HRP20080538T3 (en) | Aryloxyethylamine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition | |
| DK0806413T3 (da) | 2-substituerede viatmin D3-derivater | |
| DK0836852T3 (da) | Anvendelse af amlexanox til fremstilling af et lægemiddel til behandling af aftøse sår | |
| DE60130916D1 (de) | Neue beta-lactamverbindungen und verfahren zu deren herstellung | |
| DK1072601T3 (da) | 4-Arylpiperidinderivater til behandling af pruritus | |
| EA200101050A1 (ru) | Замещенные бензолактамные соединения | |
| EP1908752A4 (fr) | Nouveau dérivé de 2-quinolone | |
| CO5580804A2 (es) | Derivados de diazepanes utiles como inhibidores de lfa | |
| EA200500922A1 (ru) | Производные имидазола, обладающие аффиностью по отношению к альфа2 рецепторам | |
| ATE478884T1 (de) | Oligosaccharidderivat | |
| DE602006020458D1 (de) | Carbonsäureamidverbindung und deren verwendung | |
| FR2835834B1 (fr) | Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments | |
| BRPI0516549A (pt) | derivados de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)alquil ]fosfÈnico e métodos para sua fabricação | |
| MXPA05004114A (es) | Derivados de 3-(ciclopenten-1-il)-bencil-0 3-(ciclopenten-1-il)-heteroarilmetil-amina y uso de los mismos como medicinas para tratar esquizofrenia. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |